First Prospective Study on the Effect of Shank3 Deficiency on Phelan-McDermid Syndrome

Published June 11, 2013 in Molecular Autism

ASF Scientific Advisory Board Member, Joe Buxbaum, directed the first prospective study on the effects of Shank3 deficiency on a subtype of autism called 22q13 Deletion Syndrome, also known as Phelan-McDermid Syndrome.

http://www.molecularautism.com/content/pdf/2040-2392-4-18.pdf

Filed under: , , , , ,